Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Chronic kidney disease
•
Nephrology
Under what circumstances would you use tenapanor over more frequently prescribed phosphorus binders for managing hyperphosphatemia in CKD patients?
Related Questions
Do you recommend vitamin C supplementation with PO iron in patients with iron deficiency?
What are some practical tips for when a patient's consistently stated goals of care do not correlate with their actions?
How do you approach patients who are inappropriately worried/fixated on a test result that is flagged as abnormal but not clinically significant?
How do you advise a patient with CKD who wants to take an herbal medication that is not known to be nephrotoxic, given that herbal medications are not regulated?
Do you use biomarkers to improve risk prediction in patients with ADPKD during early disease stages?
How would you advise a CKD patient who asks about oral NSAIDs for management of chronic pain if they have a contraindication to taking acetaminophen?
How do you approach counseling the family of a patient with advanced CKD and dementia when discussing the options and implications of starting dialysis?
Would you start patiromer in a patient with CKD who has persistent hyperkalemia despite taking sodium zirconium cyclosilicate and adherence to a low potassium diet?
Under what circumstances would you initiate hemodialysis for fetal protection in a pregnant patient with CKD Stage 4 who does not have any usual indications to start dialysis?
Is it safe to use acarbose in patients with advanced chronic kidney disease?
